CN Patent

CN112587489A — 一种治疗丙肝的复方制剂及其制备方法

Assigned to Sichuan University · Expires 2021-04-02 · 5y expired

What this patent protects

本发明公开了一种治疗丙肝的复方制剂及其制备方法，该复方制剂是由Sofosbuvir、Fopitasvir、乳糖、微晶纤维素、交联羧甲基纤维素钠、聚维酮和硬脂酸镁制成的片剂，其中Sofosbuvir和Fopitasvir的质量比为6‑7:0.5‑1。该制剂可有效解决现有的制剂存在的副作用大，治疗效果差的问题。

USPTO Abstract

本发明公开了一种治疗丙肝的复方制剂及其制备方法，该复方制剂是由Sofosbuvir、Fopitasvir、乳糖、微晶纤维素、交联羧甲基纤维素钠、聚维酮和硬脂酸镁制成的片剂，其中Sofosbuvir和Fopitasvir的质量比为6‑7:0.5‑1。该制剂可有效解决现有的制剂存在的副作用大，治疗效果差的问题。

Drugs covered by this patent

Patent Metadata

Patent number: CN112587489A
Jurisdiction: CN
Classification: —
Expires: 2021-04-02
Drug substance claim: No
Drug product claim: No
Assignee: Sichuan University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.